(713c) Molecular Recognition of CCR5 By Macrophage Inflammatory Proteins CCL3 and CCL4 Conference: AIChE Annual MeetingYear: 2015Proceeding: 2015 AIChE Annual MeetingGroup: Engineering Sciences and FundamentalsSession: Thermodynamics of Biomolecular Folding and Assembly Time: Thursday, November 12, 2015 - 1:06pm-1:24pm Authors: Tamamis, P., TAMU Koskosidis, A., Texas A&M University Floudas, C. A., Princeton University Yildirim, M., Texas A&M University Chemokines CCL3 (Macrophage Inflammatory Protein 1α or MIP-1α) and CCL4 (MIP-1β) are crucial to immune responses to infection and inflammation. They can be induced in multiple activated cell types and can attract activated and memory T-cells to damaged sites [1,2]. CCL3 has a direct effect on T-cell differentiation . MIP-1 family members orchestrate acute and chronic inflammatory host responses at sites of injury or infection mainly by recruiting proinflammatory cells). They are crucial for T-cell chemotaxis from the circulation to inflamed tissue and also play an important role in the regulation of transendothelial migration of monocytes, dendritic cells, and NK cells . Despite their significant biological role, growing evidence has identified certain detrimental roles of the CCL3 : CCR5 and CCL4 : CCR5 complexes. The CCL3 : CCR5 signaling is associated with lung metastasis. In addition, CCL3/CCL4 secretion occurs due to B cell activation within lymphoid tissues, and this leads to the recruitment of CCR5+ regulatory T cell for cognate interactions with B cells and antigen representing cells [5,6]; this suggests that CCL3:CCR5 and CCL4:CCR5 axes possess a key role in chronic lymphocytic leukemia. Moreover, CCL3 and CCL4 are involved in multiple myeloma, melanoma, ovarian cancer [ref. and references therein]. Due to the pivotal role of proteins CCL3 and CCL4 in cancer, and in additional human pathology, e.g., in diseases associated with the central nervous system, respiratory system gastro-intestinal system etc. [ref. and references therein], the elucidation of the molecular recognition of CCR5 by CCL3 and CCL4 is of utmost importance. We have introduced our computational protocol [10,11,12,13]which is primarily based on docking, binding free energy calculations, and molecular dynamics simulations, and present, what are to our knowledge, the first complete computationally derived structures of CCR5 in complex with CCL3 and CCL4 which are in remarkable agreement with previous experimental data. Our study identifies the functional role of the receptor and chemokine residues which are involved in binding and signaling. The computational protocol used in this study was enriched through the use of additional features such as targeted molecular dynamics simulations. We compare our findings with recent X-ray derived structures of a viral chemokine in complex with CXCR4  and chemokine CX3CL1 in complex with a viral G protein-coupled receptor . Our findings can be used to design novel CCR5-targeted potential therapeutic agents (e.g., for HIV and cancer). References 1. Ren M, Guo Q, Guo L, Lenz M, Qian F, Koenen RR, Xu H, Schilling AB, Weber C, Ye RD, Dinner AR, Tang WJ. (2010) Polymerization of MIP-1 chemokine (CCL3 and CCL4) and clearance of MIP-1 by insulin-degrading enzyme. EMBO J. 29: 3952-3966. 2. Luther SA, Cyster JG. (2001) Chemokines as regulators of T cell differentiation. Nat Immunol 2: 102-107. 3. Maurer M, von Stebut E. (2004) Macrophage inflammatory protein-1. Int J Biochem Cell Biol. 36: 1882-1886. 4. Wu Y, Li YY, Matsushima K, Baba T, Mukaida N. (2008) CCL3-CCR5 axis regulates intratumoral accumulation of leukocytes and fibroblasts and promotes angiogenesis in murine lung metastasis process. Journal of Immunology 181: 6384–6393. 5. Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG. (2001) B cells and professional APCs recruit regulatory T cells via CCL4. Nature Immunology 2:1126–1132. 6. Castellino F, Huang AY, Altan-Bonnet G, Stoll S, Scheinecker C, Germain RN. (2006) Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature 440: 890–895. 7. Burger JA. (2010) Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): from understanding the basics towards therapeutic targeting. Semin Cancer Biol 20: 424-430. 8. Aldinucci D, Colombatti A. (2014) The Inflammatory Chemokine CCL5 and Cancer Progression. Mediators of Inflammation 2014: 292376 9. Menten P, Wuyts A, Van Damme J. (2002) Macrophage inflammatory protein-1. Cytokine Growth Factor Rev 13: 455-481. 10. Tamamis P, Floudas CA. (2013) Molecular Recognition of CXCR4 by a Dual Tropic HIV-1 gp120 V3 Loop. Biophysical Journal 105: 1502-1514. 11. Tamamis P, Floudas CA. (2014) Molecular Recognition of CCR5 by an HIV-1 gp120 V3 Loop. PLoS ONE 9: e95767. 12 Tamamis P, Floudas CA. (2014) Elucidating a Key Component of Cancer Metastasis: CXCL12 (SDF-1α) Binding to CXCR4. Journal of Chemical Information and Modeling 54: 1174-1188. 13. Tamamis P, Floudas CA. (2014) Elucidating a Key Anti-HIV-1 and Cancer-Associated Axis: The Structure of CCL5 (Rantes) in Complex with CCR5. Scientific Reports 4: 5447. 14. Qin L, Kufareva I, Holden LG, Wang C, Zheng Y, Zhao C, Fenalti G, Wu H, Han GW, Cherezov V, Abagyan R, Stevens RC, Handel TM. Structural biology. (2015) Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine. Science 347: 1117-11122. 15. Burg JS, Ingram JR, Venkatakrishnan AJ, Jude KM, Dukkipati A, Feinberg EN, Angelini A, Waghray D, Dror RO, Ploegh HL, Garcia KC. (2015) Structural biology. Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor. Science 347: 1113-1117.